Fifth disease
☆ AI Dermatology — Free Service
Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
16-bilood jir ah oo qaba Fifth disease – labada dhabarba way guduudan yihiin, sida in la dharbaaxay, waxaana jirka ka soo baxa finan maculopapular ah.
Erythema labada dhaban.
relevance score : -100.0%
ReferencesFifth disease, sidoo kale loo yaqaan erythema infections, waa caabuq fayras ah oo uu keeno parvovirus B19 ee bini'aadamka. Waxay aad ugu badan tahay carruurta, caadi ahaan waxay saamaysaa kuwa da'doodu u dhaxayso 4 ilaa 14 sano. Calaamadaha waxay inta badan ku bilaabmaan qandho fudud, madax-xanuun, cune xanuun, iyo dareen hargab la mid ah. Carruurtu waxay soo bandhigi karaan finan guduudan oo kala duwan oo wejiga u eg 'slapped cheeks', oo ay la socdaan finan qaabaysan oo ku yaal jidhka, gacmaha, iyo lugaha. Dadka qaangaarka ah, xanuunka kala-goosyadu waa cabasho caadi ah, taas oo soo bixi karta toddobaadyo kadib caabuqa bilowga ah. Gaar ahaan, qiyaastii 20 ilaa 30% dadka qaangaarka ah ee qaba parvovirus B19 lagama yaabo inay muujiyaan wax calaamado ah.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Khatarta ay hooyada parvovirus B19 uga gudbi karto ilmaha waa ilaa 33%, iyadoo qiyaastii 3% haweenka cudurka qaba ay dhibaatooyin kala kulmaan ilmahooda. Marka hooyadu qaadato cudurka ka hor 20‑ka usbuuc ee uurka, fursadda dhibaatooyinka sida anemiya iyo dheecaanka ku urura jidhka ilmaha ayaa kordha. Si aan u bilowno maaraynta cudurkan, waa in aan hubinno in bukaanku waligiis la kulmay parvovirus B19 annagoo ka baarayna unugyada difaaca jirka (IgM). Haddii baaritaanku aanu muujinin infekshan hore balse uu tilmaamayo infekshan dhawaan dhacay, bukaanka waxa uu u baahan yahay la‑socod dhow inta uu uurka leeyahay, oo ay ku jiraan baarista ultrasound‑ka caadiga ah si loo eego xaaladaha caafimaad ee ilmaha.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
Fifth disease waxa ay ku bilaabataa qandho hoose, madax-xanuun, finan, iyo calaamado hargab u eg, sida sanka oo duufsan ama ciriiri ah. Calaamadahani way baaba'aan, ka dibna dhowr maalmood ka dib, finanku waxay soo baxaan. Finanka cas ee dhalaalaya badanaa waxay ka soo baxaan wejiga, gaar ahaan dhabannada (sidaa darteed magaca "cudurka dhabanka dharbaaxay"). Dhabannada gaduudan ka sokow, carruurtu waxay inta badan helaan finan cas oo ka muuqda maqaarka meelaha kale, iyadoo gacmaha, lafaha, iyo lugaha ay yihiin meelaha ugu badan.
Cudurku inta badan waa mid fudud, laakiin haweenka uurka leh, caabuqa saddexda bilood ee ugu horreeya waxaa lala xiriiriyay hydrops fetalis, taasoo keenta dhimasho iskiis ah.
○ Daawaynta
Ma jirto daaweyn gaar ah oo loo baahan yahay maadaama ay inta badan isdaba-joogto waqti ka dib.